Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil

HIGHLIGHTS

• who: W.Y. Cheung md mph et al. from the recommendation that ftd/tpi be included on the list of medications for the treatment of adult patients with mcrc for whom previous standard therapies have failed Since August, ftd/tpi has been reimbursed for patients with mcrc in Quebec under the Régie de l'assurance maladie du Québec, have published the Article: Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil, in the Journal: (JOURNAL) of 27/Nov/2018
• what: The aim was to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.